Source: Abstracts. Conference titles: AIDS Vaccine. Unidade: FM
Subjects: HIV, VACINAS VIRAIS, SÍNDROME DE IMUNODEFICIÊNCIA ADQUIRIDA (TRANSMISSÃO;PREVENÇÃO E CONTROLE)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONSECA, S. et al. Novel conserved immunodominant CD4+ Tcell epitopes from clade B HIV-1 are frequently recognized by HIV-1 infected patients in different disease stages following haart and in long term non progressors. 2005, Anais.. Quebec: Faculdade de Medicina, Universidade de São Paulo, 2005. p. 161. . Acesso em: 02 nov. 2024.APA
Fonseca, S., Mairena, E., Fonseca, L. A., Leite, O., Silva, A., Sidney, J., et al. (2005). Novel conserved immunodominant CD4+ Tcell epitopes from clade B HIV-1 are frequently recognized by HIV-1 infected patients in different disease stages following haart and in long term non progressors. In Abstracts (p. 161). Quebec: Faculdade de Medicina, Universidade de São Paulo.NLM
Fonseca S, Mairena E, Fonseca LA, Leite O, Silva A, Sidney J, Sette A, Segurado A, Morais S, Santos S, Rodrigues H, Hammer J, dell'Agnolo R, Kalil J, Li H, Iwai L, Silva B. Novel conserved immunodominant CD4+ Tcell epitopes from clade B HIV-1 are frequently recognized by HIV-1 infected patients in different disease stages following haart and in long term non progressors. Abstracts. 2005 ; 161.[citado 2024 nov. 02 ]Vancouver
Fonseca S, Mairena E, Fonseca LA, Leite O, Silva A, Sidney J, Sette A, Segurado A, Morais S, Santos S, Rodrigues H, Hammer J, dell'Agnolo R, Kalil J, Li H, Iwai L, Silva B. Novel conserved immunodominant CD4+ Tcell epitopes from clade B HIV-1 are frequently recognized by HIV-1 infected patients in different disease stages following haart and in long term non progressors. Abstracts. 2005 ; 161.[citado 2024 nov. 02 ]
